Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Global Blood Therapeutics, Inc.

http://www.globalbloodtx.com/index.php

Latest From Global Blood Therapeutics, Inc.

Co-Inventor Of mRNA Tech Goes After Sickle Cell Anemia

After a chance encounter at a photocopy machine brewed the recipe for Pfizer and Moderna’s success with mRNA vaccines, Dr Drew Weissman has set sights on developing a single-injection therapy for sickle cell anemia.

Research & Development Rare Diseases

Fears For Ukraine’s Access To Medicines And Trials As Russian Invasion Continues

The European pharma sector is looking to maintain supplies of essential medicines to Ukraine and Russia as invasion continues, while a US biopharma group is calling for industries to boycott all non-food and medical trade with Russia.

Ukraine Politics

Fears For Ukraine’s Access To Medicines And Trials As Russian Invasion Continues

The European pharma sector is looking to maintain supplies of essential medicines to Ukraine and Russia as invasion continues while a US biopharma group is calling for industry to boycott all non-food and medical trade with Russia.

Europe Ukraine

Hits, Misses & Key Firsts For EMA’s PRIME Scheme

The rate at which investigational drugs were accepted onto the European Medicines Agency’s priority medicines scheme dropped in 2021. Meanwhile, more much-needed treatments that had been developed under the scheme went on to win EU marketing approval.

Europe Research & Development
See All

Company Information

UsernamePublicRestriction

Register